SE8500620L - Analys med avseende pa interferon epsilon - Google Patents

Analys med avseende pa interferon epsilon

Info

Publication number
SE8500620L
SE8500620L SE8500620A SE8500620A SE8500620L SE 8500620 L SE8500620 L SE 8500620L SE 8500620 A SE8500620 A SE 8500620A SE 8500620 A SE8500620 A SE 8500620A SE 8500620 L SE8500620 L SE 8500620L
Authority
SE
Sweden
Prior art keywords
preparation
interferon epsilon
cells
subcultures
keratinocytes
Prior art date
Application number
SE8500620A
Other languages
English (en)
Swedish (sv)
Other versions
SE8500620D0 (sv
Inventor
R H L Pang
Original Assignee
Damon Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc
Publication of SE8500620D0 publication Critical patent/SE8500620D0/xx
Publication of SE8500620L publication Critical patent/SE8500620L/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8500620A 1984-07-06 1985-02-12 Analys med avseende pa interferon epsilon SE8500620L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/628,612 US4675282A (en) 1984-07-06 1984-07-06 Assay for interferon epsilon

Publications (2)

Publication Number Publication Date
SE8500620D0 SE8500620D0 (sv) 1985-02-12
SE8500620L true SE8500620L (sv) 1986-01-07

Family

ID=24519613

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8500620A SE8500620L (sv) 1984-07-06 1985-02-12 Analys med avseende pa interferon epsilon

Country Status (14)

Country Link
US (1) US4675282A (de)
JP (1) JPS6125060A (de)
AU (1) AU3857085A (de)
BE (1) BE902663A (de)
CA (1) CA1244345A (de)
CH (1) CH666285A5 (de)
DE (1) DE3515803A1 (de)
DK (1) DK99185A (de)
FR (1) FR2567269A1 (de)
GB (1) GB2161270A (de)
IT (1) IT1183809B (de)
NL (1) NL8501564A (de)
NO (1) NO850536L (de)
SE (1) SE8500620L (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296158B1 (de) * 1986-03-06 1992-06-17 Commonwealth Scientific And Industrial Research Organisation In-vitro-testverfahren zum nachweis zellulärer immunresponsen
CA2311681A1 (en) 1997-12-08 1999-06-17 Genentech, Inc. Human interferon-epsilon: a type i interferon
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
JP2007519422A (ja) 2004-02-02 2007-07-19 アンブレツクス・インコーポレイテツド 修飾されたヒト四螺旋バンドルポリペプチド及びそれらの使用
SG188143A1 (en) 2008-02-08 2013-03-28 Ambrx Inc Modified leptin polypeptides and their uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1443425A (en) * 1972-10-25 1976-07-21 Searle & Co Interferon assay
US3910824A (en) * 1973-10-18 1975-10-07 Searle & Co Interferon assay
US4241174A (en) * 1978-11-24 1980-12-23 Hoffmann-La Roche Inc. Interferon assay
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
FR2531865A1 (fr) * 1982-07-12 1984-02-24 Damon Biotech Inc Preparation a base d'interferon et son procede de fabrication
IL66733A (en) * 1982-09-07 1986-03-31 Yeda Res & Dev Assay for ifn and kit therefor

Also Published As

Publication number Publication date
FR2567269A1 (fr) 1986-01-10
IT1183809B (it) 1987-10-22
CA1244345A (en) 1988-11-08
GB8517164D0 (en) 1985-08-14
NO850536L (no) 1986-01-07
NL8501564A (nl) 1986-02-03
IT8567398A0 (it) 1985-04-30
AU3857085A (en) 1986-01-09
DE3515803A1 (de) 1986-01-16
IT8567398A1 (it) 1986-10-30
DK99185D0 (da) 1985-03-04
GB2161270A (en) 1986-01-08
SE8500620D0 (sv) 1985-02-12
DK99185A (da) 1986-01-07
US4675282A (en) 1987-06-23
JPS6125060A (ja) 1986-02-03
CH666285A5 (de) 1988-07-15
BE902663A (fr) 1985-09-30

Similar Documents

Publication Publication Date Title
Bertolotto et al. Interferon β neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations
AU7165987A (en) In vitro assay for detecting cell-mediated immune responses
ATE268904T1 (de) Zellbasiertes festphasentest
NO950426D0 (no) Analyse for bestemmelse av protein i en biologisk pröve
SE8500620L (sv) Analys med avseende pa interferon epsilon
Land et al. Rapid diagnosis of herpes simplex virus infections by enzyme-linked immunosorbent assay
AR245534A1 (es) Conjunto de reactivos (kit) de aplicacion en inmunoensayos para enzimas
Herrera et al. Immune response impairment, genotoxicity and morphological transformation induced by Taenia solium metacestode
Schnipper et al. Virus replication and induction of interferon in human epidermal keratinocytes following infection with herpes simplex virus.
Benjamin Use of immunoperoxidase for rapid diagnosis of mucocutaneous herpes simplex virus infection
EP0105221A1 (de) Verfahren zur Bestimmung von Interferon und Satz zur Prüfung von Interferon
ES2001864A6 (es) Un metodo de determinacion de la presencia de anticuerpos contra las glicoproteinas ga, gb y gc de vzv y un dispositivo de diagnostico
Henderson et al. Industrial Genotoxicology Group collaborative trial to investigate cell cycle parameters in human lymphocyte cytogenetics studies
EP0302997A3 (de) Verfahren zum Nachweis von Antikörpern gegen das menschliche Immunomangelhaftigkeitsvirus
Bailey et al. A multidonor ELISPOT study of IL-1β, IL-2, IL-4, IL-6, IL-13, IFN-γ and TNF-α release by cryopreserved human peripheral blood mononuclear cells
Méo et al. Applicability of the SOS Chromotest to detect urinary mutagenicity caused by smoking
Minuth et al. Differentiation properties of renal collecting duct cells in culture
Agut et al. Simplified test for detecting the resistance of herpes simplex virus to acyclovir
Mia et al. A micro-enzyme-linked immunosorbent assay (ELISA) test for detection of feline leukemia virus in cats
Gronowitz et al. A sensitive assay for detection of deoxythymidine kinase and its application to herpesvirus diagnosis
DK0674718T3 (da) Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi
Goldberg et al. The Diagnostic accuracy of three recommended methods for serum aspartate aminotransferase assays in patients suspected of myocardial infarction and hepatobiliary diseases
DE69033072T2 (de) Verfahren und Mittel zum Nachweis von Krankheitszuständen aus Änderungen im Östrogenstoffwechsel
Pepin et al. Comparison of two methods for rapid detection of cytomegalovirus viraemia in cell culture
Merli et al. Quantitation of Toxoplasma-induced cytopathic effect (CPE) in vitro by the assessment of cell numbers via the endogenous enzyme, hexosaminidase

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8500620-3

Effective date: 19890901